Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile

Journal of Infectious Diseases

Volumn 195, Issue 11, 2007, Pages 1563-1571

  Ferrés, Marcela ^a   Vial, Pablo ^b   Marco, Claudia ^b   Yañez, Lia ^b   Godoy, Paula ^b   Castillo, Constanza ^d   Hjelle, Brian ^e   Delgado, Iris ^c   Lee, Sang Joon ^e   Mertz, Gregory J ^e  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

^c UNIVERSIDAD DEL DESARROLLO   (Chile)

^d UNIVERSIDAD DE LA FRONTERA   (Chile)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BLOOD CELL; CHILE; CONTROLLED STUDY; FEMALE; HANTAVIRUS PULMONARY SYNDROME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEXUALITY; VIREMIA; VIRUS DETECTION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHILE; CONTACT TRACING; FAMILY CHARACTERISTICS; FEMALE; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; VIREMIA;

EID: 34249042292     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516786     Document Type: Article

References (24)

1. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis 1997; 3:95-104.
2. Duchin JS, Koster F, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994; 330:949-55.
3. Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of the hantavirus pulmonary syndrome. Crit Care Med 1996; 24:252-8.
4. Sotomayor V, Aguilera X. Epidemiology of human infection with hantavirus in Chile. Rev Chil Infect 2000; 17:220-32.
5. Torres-Pérez F, Navarrete-Droguett J, Aldunate R, et al. Peridomestic small mammals associated with confirmed cases of human hantavirus disease in southcentral Chile. Am J Trop Med Hyg 2004; 70:305-9.
6. Mertz GJ. Bunyaviridae: bunyaviruses, phleboviruses, nairoviruses, and hantaviruses. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology. 2nd ed. Washington, DC: American Society for Microbiology Press, 2002:921-48.
7. Pini N. Hantavirus pulmonary syndrome in Latin America. Curr Opin Infect Dis 2004; 17:427-31.
8. Martinez VP, Bellomo C, San Juan J, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis 2005; 11:1848-53.
9. Padula PJ, Edelstein A, Miguel SD, Lopez NM, Rossi CM, Rabinovich RD. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 1998; 241:323-30.
10. Wells RM, Sosa Estani S, Yadon ZE, et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg Infect Dis 1997; 3:171-4.
11. Castillo C, Villagra E, Sanhueza L, Ferres M, Mardones J, Mertz GJ. Prevalence of antibodies to hantavirus among family and healthcare worker contacts of persons with hantavirus cardiopulmonary syndrome in Chile: lack of evidence for nosocomial transmission of Andes virus to healthcare workers in Chile. Am J Trop Med Hyg 2004; 70:302-4.
12. Galeno H, Mora J, Villagra E, et al. First human isolate of hantavirus (Andes virus) in the Americas. Emerg Infect Dis 2002; 8:657-60.
13. Rossi C, Ksiazek T. Virus detection and identification with serological tests. 11. Enzyme-linked immunosorbent assay (ELISA). In: Lee HW, Calisher C, Schmaljohn C, eds. Manual of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Seoul: WHO Collaborating Centre for Virus Reference and Research (Hantavirus), 1999:87-91.
14. Ksiazek TG, Peters CJ, Rollin PE. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg 1995; 52:117-23.
15. Bharadwaj M, Nofchissy R, Goade D, Koster F, Hjelle B. Humoral immune responses to the hantavirus cardiopulmonary syndrome. J Infect Dis 2000; 182:43-8.
16. Botten J, Mirowsky K, Ye C, et al. Shedding and intracage transmission of Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus) model. J Virol 2002; 76:7587-94.
17. Vial PA, Valdivieso F, Mertz G, et al. The incubation period of hantavirus cardiopulmonary syndrome. Emerg Infect Dis 2006; 12:1271-3.
18. Hooper JW, Larson T, Custer DM, Schmaljohn C. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001; 289:6-14.
19. Mertz GJ, Hjelle BL, Williams TM, Koster FT. Host responses in the hantavirus cardiopulmonary syndrome. In: Saluzzo JR, Dodet B, eds. Factors in the emergence and control of rodent-borne viral diseases. New York: Elsevier, 1999:133-7.
20. Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA. Role of specific DE8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 2004; 172:3297-304.
21. Padula P, Figueroa R, Navarrete M, et al. Transmission study of Andes hantavirus infection in wild sigmodontine rodents. J Virol 2004; 78:11972-9.
22. Merino C, Arias A, Castillo C. First case of hantavirus cardiopulmonary syndrome secondary to a rodent bite. Rev Chil Enf Respir 2002; 18:199-205.
23. St Jeor SC. Three-week incubation period for hantavirus infection. Pediatr Infect Dis J 2004; 23:974-5.
24. Dourou E, Moriniere B, Matheron S, et al. HFRS after a wild rodent bite in the hautesavoie and risk of exposure to a hantaan-like virus in a Paris laboratory. Lancet 1984; 1:676-7.